Answer #1: For a typical 165lb patient receiving Leqembi every two weeks, the list price works out to roughly $2,300 per month (about $26,500 a year).
Answer #2: Medicare usually picks up around 80% of that amount, so most people on Medicare see an outofpocket bill of about $440 per month (around $5,300 a year).
Thats the headlinelevel info most of you are hunting for, but theres a lot more nuance behind those numbers. Lets break it all down together, step by step, so you know exactly where your money is going and how you might keep it lower.
Price Foundations
How the list price is calculated
Vialbased pricing
Leqembi comes in singleuse vials. A 165lb adult typically needs two vials per infusion. Each vial is priced at about $13,250, so two vials equal $26,500 for a full year of treatment (that\'s 24 infusions, one every two weeks).
Frequency of infusions
The everytwoweeks schedule is built into the clinical trial design and the FDA label. If you miss an appointment, you dont get a credit the next dose comes at the regular interval, so the monthly cost stays steady.
The role of Medicare & private insurance
Medicare PartB coverage
Medicare counts Leqembi as a PartB drug. That means it adds a 4.3% administration fee on top of the drug price and then covers roughly 80% of the total. The remaining 20% (plus the 4.3% fee) lands on your shoulders.
Typical privateinsurance negotiations
Commercial insurers negotiate rebates directly with Eisai, the maker of Leqembi. Those rebates can shave 1030% off the list price, but the exact amount varies by plan. If you have a highdeductible health plan, you might see a bigger initial bill before the insurer steps in.
Comparing Leqembi to other FDAapproved Alzheimers drugs
Kisunla cost per month
Kisunla (donanemab) is priced at about $3,200 per month in 2025, which is roughly $900 more than Leqembis list price.
Lecanemab price USA
Leqembi is actually the brand name for lecanemab, and the U.S. list price is the same $26,500 per year. Some reports lump the two together, but the pricing is identical.
Realworld outofpocket examples
Case Study1: Patient A (Medicare)
Maria, 72, weighs 160lb. She gets two vials each infusion. With Medicare covering 80% and the 4.3% markup, her outofpocket cost is about $440 a month.
Case Study2: Patient B (private insurance)
John, 68, has a highdeductible PPO. His insurer negotiated a 20% rebate, so the net price is $21,200 per year. After his deductible, he ends up paying roughly $1,800 per month.
Saving Strategies
Medicare & supplemental plans
What 80% coverage really means
Its not a flat discount. Medicare first pays 80% of the drug price, then adds the 4.3% administration fee, and finally applies any supplemental coverage you have (like Medigap). Those extra policies can further reduce the $440amonth figure.
How a Medicare Advantage plan may lower the monthly premium
Some Medicare Advantage (MA) plans bundle drug costs into a single premium, often with lower outofpocket caps. If youre eligible, switching to an MA plan that includes Leqembi could shave off $100$200 each month.
Manufacturer assistance programs
Eisais Patient Assistance & CopayAssist programs
Eisai offers a that can cover up to $500 a month for qualifying patients (based on income and insurance status). The application takes about 15minutes and can be started online.
Eligibility checklist (income, insurance status)
Generally you need to be a U.S. resident, have a valid prescription, and meet a household income threshold (usually below $100,000). If youre on Medicare, youre automatically eligible for the additional Medicare Savings Program.
Pharmacybenefit managers & discount cards
How PBMs negotiate lower vial prices
Pharmacybenefit managers (PBMs) act as middlemen between insurers and drug manufacturers. By bundling large volumes, they can secure rebates that lower the pervial cost. Ask your pharmacist if they work with a PBM that offers a Leqembi discount card.
Sample discountcard application steps
1. Visit the PBM website.
2. Fill out a short questionnaire about your diagnosis and insurance.
3. Print the card and present it at the infusion center.
4. Watch the price drop on your next statement.
Timing & dosing strategies
Weightbased dosing vs. flatdose (when possible)
Leqembi is officially weightbased, but some clinicians consider a flat dose for patients under 70kg to keep costs predictable. Talk to your neurologist about whether a flatdose protocol could be appropriate for you.
Discussing alternate infusion intervals with your neurologist
Occasionally, specialists may stretch the interval to every three weeks for stable patients, which reduces the number of infusions from 24 to 16 per yearcutting the annual cost by about onethird. This is offlabel, so make sure you understand the risks.
Benefits vs Risks
Clinical efficacy of Leqembi
Summary of Phase3 data
In the pivotal CLARITYAD trial, Leqembi slowed cognitive decline by roughly 27% over 18 months compared to placebo. It also cleared amyloid plaques on PET scans in more than 70% of participantsa first for an FDAapproved Alzheimers drug.
Link to FDA prescribing information
For the full clinical details, see the .
Common side effects & monitoring costs
Infusionrelated reactions
About 10% of patients experience mild fever, chills, or headache during the infusion. These are usually managed with a short pause and acetaminophen.
ARIAE (brain swelling) and MRI followup
Leqembi can cause AmyloidRelated Imaging Abnormalities (ARIAE). Guidelines recommend an MRI at baseline, then after the first three infusions, and annually thereafter. Each MRI adds $200$300 to your yearly bill, a cost youll want to factor in.
Qualityoflife impact
Patientreported outcomes
Surveys from the Alzheimers Association indicate that patients who stay on Leqembi for at least a year report feeling more independent and experience slower loss of dailyliving skills.
Economic modeling: longer independence vs. higher cost
One 2024 healtheconomics model estimated that for every $10,000 spent on Leqembi, families could save up to $15,000 in caregiving costs over three years, thanks to delayed institutionalization.
When to consider alternatives (e.g., Kisunla)
Cost comparison table (Leqembi vs. Kisunla)
| Drug | List Price/Year | Approx.Monthly Cost* | Medicare Coverage | Typical OutofPocket (monthly) |
|---|---|---|---|---|
| Leqembi | $26,500 | $2,300 | 80% (PartB) | $440 (Medicare) $1,800 (private) |
| Kisunla | $38,400 | $3,200 | 80% (PartB) | $640 (Medicare) $2,560 (private) |
*Based on average dosing; individual weight may shift numbers.
Clinical scenario checklist
Consider Kisunla if:
- You have a higher monthly budget.
- Your neurologist believes the slightly higher amyloid clearance is worth the extra cost.
- Your insurance offers a better rebate for Kisunla than for Leqembi.
Quick FAQs
What is the monthly price of Leqembi?
About $2,300/month at list price; Medicare typically reduces the outofpocket amount to roughly $440/month.
How many vials does a patient need for each infusion?
Dosing is weightbased. A 165lb adult usually needs two vials per infusion.
Does Medicare cover Leqembi?
Yes. Medicare PartB covers about 80% of the drug cost plus a 4.3% administration fee.
Is Leqembi covered by private insurance?
Most commercial plans do cover it, but the exact copay depends on negotiated rebates and your specific plan design.
What are the main side effects?
Infusion reactions, mild fever, headache, and the possibility of ARIAE, which requires periodic MRI scans.
How does Leqembi compare to Kisunla costwise?
Kisunla averages $3,200/month, making it about $900 more expensive than Leqembis list price.
Can I get financial help for Leqembi?
YesEisai offers a copayassist program, and Medicare Savings Programs can further lower your bill.
Bottom Line
Putting it all together, the headline number youll see on a drug price sheet is about $2,300 per month. If youre on Medicare, youll likely pay closer to $440 each month after the government steps in. Private insurers can vary widelysome may leave you paying $1,800 or more per month.
Heres a quick action plan for anyone facing this decision:
- Use a simple weightbased calculator (search Leqembi vial calculator) to see how many vials youll need.
- Call Medicare and your insurer to confirm exact coverage percentages and any supplemental plan options.
- Apply for Eisais copayassist program right away; the paperwork is painless and can shave a few hundred dollars off each month.
- Ask your neurologist whether a flatdose or extendedinterval schedule might be safe for you.
- Weigh the clinical benefits (slower cognitive decline, improved independence) against the costs and potential sideeffects like ARIAE.
Understanding the numbers empowers you to have an informed conversation with your doctor and your insurance rep. If youve already navigated the cost maze, Id love to hear what worked for you. Got more questions? Drop a comment below, and lets keep the conversation going. After all, were all in this together, and the more we share, the easier it gets to make the right choices for our health and our wallets.
For families exploring broader neurological diagnoses while considering treatment costs, resources on Rett syndrome types can be helpful background readingsome caregivers find the diagnostic criteria and care discussions relevant when planning long-term support and finances.
FAQs
What is the typical monthly cost of Leqembi before insurance?
The list price works out to about $2,300 per month for a 165‑lb patient who receives two vials every two weeks.
How much does Medicare cover for Leqembi and what is the patient’s out‑of‑pocket amount?
Medicare Part B pays roughly 80 % of the drug price plus a 4.3 % administration fee, leaving most beneficiaries with an out‑of‑pocket bill of around $440 each month.
Can private insurance reduce the cost of Leqembi and how?
Commercial insurers negotiate rebates with Eisai that can shave 10‑30 % off the list price. After deductibles and co‑pays, patients may still pay between $1,000 and $2,000 per month.
Are there any patient‑assistance programs available for Leqembi?
Eisai offers a copay‑assist program that can cover up to $500 per month for qualifying patients, and Medicare Savings Programs can further lower costs for low‑income beneficiaries.
What additional medical expenses should patients expect while on Leqembi?
Periodic MRI scans to monitor for ARIA‑E add roughly $200‑$300 per scan, and occasional mild infusion‑related reactions may require simple over‑the‑counter treatments.
